×
English
हिंदी
ગુજરાતી
Home
My Feed
Remove Ads
Get Premium Content
Go Pro @₹99
Credit Cards
Instant Loans
Apply Now
Credit Score
Refer & Earn ₹500
Refer Now
Finance Tracker
Learning Curve
Fixed Deposits
Business Loan
Markets
Markets
FII & DII Activity
Corporate Action
Research Advice
Earnings
Technical Trends
Stock Deals
Intraday Large Deals
Bonds
Webinar
Pre Market
Stock Scanner
Sector Analysis
Unlisted Shares
Stock Updates
PRO Stock Lists
Monsoon Tracker
Seasonality Analysis
Crypto Dashboard
Web Stories
Tax Calculator
Forum
Gold Rate
Silver Rate
IFSC Code Finder
Storyboard18
IPO
Economic Indicators
Economic Calendar
Global Markets
US Markets
ETFs
Indian Indices
News
News
Tech/Startups
Auto
Research
Opinion
Politics
Personal Finance
EPF Guide
Real Estate
Portfolio
Watchlist
Personal Finance
Personal Finance
Loans
Fixed Deposit Comparison
Fixed Deposit Interest Calculator
Moneycontrol - SecureNow Health Insurance ratings
Mutual Funds
Mutual Funds
Performance Tracker
Top ranked funds
My Portfolio
Top performing Categories
Forum
New Fund Offers
MF Simplified
Commodities
Mutual Funds
Gold Rate
Silver Rate
Currencies
Cryptocurrency
Media
Live TV & Shows
Video
Podcast
Photos
Invest Now
Trade like Experts
Invest in Unlisted Shares
Specials
Pharma Industry Conclave
Unlocking opportunities in Metal and Mining
#MFSummit2025
Moneycontrol mutual fund summit 2025
Advanced Technical Charts
International
Get App
Be a
Pro
Home
PRO
Markets
News
Editor’s Picks
Tech
India
Learning Curve
Portfolio
Watchlist
Commodities
MF
Personal Finance
Forum
Videos
you are here:
Home
News
Dr Reddy
Dr Reddy
Ads
Dr Reddy’s: Is the weight loss drug the next big opportunity?
Adani Infra, Tata Power, Dr.Reddy, JSW Steel in Focus
Why should one avoid fresh bets on Dr Reddy’s?
Dr Reddy's Laboratories incorporates wholly-owned subsidiary in Jamaica; stock rises 1%
Who makes a better suitor for Cipla and what is in it for shareholders?
Another great quarter for Dr Reddy’s, but is it sustainable?
Dr Reddy’s completes phase 1 study of key anti-rheumatic biosimilar drug
Cash Trade | Dr Reddy's bouncing off channel support
Markets extend rally to 3rd day; Sensex climbs over 300 points
Dr Reddy’s: Acceleration in EM opportunity to help re-rate company
Dr Reddy’s: Improving exposure to EMs adds to investment case
COVID-19 vaccine | India's Dr. Reddy's in talks with government to bring Russia's Sputnik Light
Deregulation of vaccine rollout: What it means for pharma players
Ideas For Profit | What the second covid-19 ‘wave’ means for domestic pharma companies?
COVID Vaccine: The opportunities for investors - Part I
Cadila: a formidable play in Covid times and beyond
Ideas For Profit | Dr Reddy’s: An opportunity for risk takers
Dr Reddy's to recall 1,752 bottles of heartburn drug in the US
Dr Reddy's launches generic lipid-regulating tablets in US
Rising stars? 14 stocks reported over 100% surge in PAT
Dr Reddy’s plummets 23% as Jefferies red flags ‘repeat’ observations
Dr Reddy’s Labs falls 4% as US FDA issues 11 observations to Bachupally plant
Upbeat CLSA view, procedural observations from US FDA send DRL stock up 3%
Dr Reddy’s tanks 6% on dismal Q1; brokerages turn cautious on stock
Dr Reddy’s US FDA developments get a thumbs up from brokerages
View More
Home
Markets
Loans
SPIN
2
WIN
News
Portfolio